GlassScriptPhysician profile
Joseph M Carbone
NPI 1245282458
$6,193.85
in general payments reported to CMS, 2019-2025
40 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,346 · 2020: $327 · 2021: $749 · 2022: $782 · 2023: $895 · 2024: $1,836 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,857 · Travel and Lodging: $1,032 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,857.28 |
| Travel and Lodging | $1,031.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,331.38 | 2024 | Aquabeam System |
| Neotract INC. | $1,055.75 | 2019 | |
| Janssen Biotech, INC. | $601.70 | 2019-2024 | Erleada |
| Myriad Genetic Laboratories, INC. | $494.27 | 2020-2023 | Prolaris |
| Axonics, INC. | $287.18 | 2020-2024 | Axonics |
| Abbvie INC. | $204.29 | 2021-2025 | Botox |
| Sumitomo Pharma America, INC. | $193.08 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $179.45 | 2019-2024 | |
| Vifor Pharma, INC. | $171.55 | 2020-2023 | Veltassa, Korsuva |
| Myovant Sciences INC. | $167.77 | 2021-2022 | |
| Medtronic USA, INC. | $133.16 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $123.69 | 2021-2023 | Acthar |
| Pfizer INC. | $121.10 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $111.27 | 2021-2024 | Lynparza |
| Allergan, INC. | $98.40 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Carbone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.